Business
ITV Announces Investment in Flarin
ITV Announces Investment in Flarin.
About this update from Itv Plc
[{"type":"text","content":"\n\nITV Announces Investment in Flarin\n \nLondon, 15 August 2023\n \nITV today announces its third 2023 deal as part of its Media for Equity portfolio, in pain relief brand Flarin - its first consumer healthcare investment to date.\n \nAs part of ITV Adventures Invest, its Media for Equity investment fund, ITV has agreed to subscribe for £2 million of shares in Flarin Holdings Limited, with the option to subscribe for two additional tranches of £1.5 million each, in return for advertising inventory across ITV's channels and ITVX. It follows ITV's recent Media for Equity investments in architectural design company Resi plus pet health and wellness company PitPat, both announced earlier this year.\n \nFlarin is a unique and patent protected anti-inflammatory painkiller. Its lipid formulation has been clinically proven to be as effective as twice the dose of standard ibuprofen in patients with acute joint pain. Flarin is one of the fastest growing analgesics in the UK and offers consumers a targeted solution for joint and muscular pain relief. It is the only lipid formulated oral analgesic available in the UK.\nITV's investment will help Flarin build mass market brand awareness by bringing the brand to millions of consumers via ITV platforms. This will be a step change in the size of the campaign and the approach to scaling the Flarin brand to date.\n \nDirector of ITV AdVentures, Sheena Amin said: \"It's fantastic to be announcing our latest Media for Equity investment into Flarin. With its innovative and patented lipid technology, Flarin offers many unique benefits to those suffering from joint and muscular pain compared to any other product on the market. Flarin is already one of the fastest growing analgesics in the market and I am confident that we will see the company grow to new heights following a brand building campaign across ITV.\"\n \nMD of Flarin, Philip Lindsell said: \"Pain and inflammation are increasing and global problems for an ageing world population. Many consumers are already finding that Flarin delivers better relief from their joint and muscular pain.\n \nWe are delighted to welcome ITV as an investor as they will be directly instrumental in promoting much wider awareness of the benefits of Flarin. We know that TV is an effective means of reaching consumers, so with the wi...